Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems.

Sand Hill Road Host Scott McGrew spoke with Jim Tananbaum to learn more about how artificial intelligence is fueling ...

10x Genomics has a fifty-two week low of $9.77 and a fifty-two week high of $45.60. The firm’s 50 day moving average price is $13.90 and its 200 day moving average price is $16.67. Get 10x ...

While at SoftBank, Nishar led deals into Slack and 10x Genomics. The departures come at a time when General Catalyst, which manages $32 billion in assets, is evolving from a partnership-model ...

Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences. On February 25, 2025, a consent agreement was ...

Background: The tumor microenvironment (TME) significantly impacts the progression and prognosis of medulloblastoma (MB). This study aimed to develop a TME-associated ...

Ultima, a relative newcomer to the field, emphasized that they are driving big projects: single cell with the Billion Cells Project (with Chan Zuckerberg Initiative (CZI) and 10x Genomics ...

Two papers published today in the journal Nature describe a significant advance ... "By transforming questions about metabolism into a genomics challenge, we were able to draw a 'wiring map ...

It features a software stock we’re confident has 10X potential. Road sign showing a fork in the road Philip Panaro is the founder and former CEO of Boston Consulting Group who clearly remains ...

Scientists now also agree that net zero can only be achieved if nature loss is prevented and — where possible — reversed, allowing it to continue to act as our most significant carbon sink. “Climate ...